Integrated semi‐physiological pharmacokinetic model for both sunitinib and its active metabolite SU12662

Publisher： John Wiley & Sons Inc

E-ISSN： 1365-2125|79|5|809-819

ISSN： 0306-5251

Source： BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (ELECTRONIC), Vol.79, Iss.5, 2015-05, pp. : 809-819

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Association Analysis of Genetic Polymorphisms in Genes Related to Sunitinib Pharmacokinetics, Specifically Clearance of Sunitinib and SU12662

By  

CLINICAL PHARMACOLOGY & THERAPEUTICS, Vol. 96, Iss. 1, 2014-07 ,pp. : 81-89

John Wiley & Sons Inc

Access to resources Recommend Favorite

Semi‐physiological model of postprandial triglyceride response in lean, obese and very obese individuals after a high‐fat meal

By  

DIABETES OBESITY & METABOLISM (ELECTRONIC), Vol. 20, Iss. 3, 2018-03 ,pp. : 660-666

John Wiley & Sons Inc

Access to resources Recommend Favorite

Oxcarbazepine and its active metabolite, (S)‐licarbazepine, exacerbate seizures in a mouse model of genetic generalized epilepsy

By  

EPILEPSIA, Vol. 56, Iss. 1, 2015-01 ,pp. : e6-e9

John Wiley & Sons Inc

Access to resources Recommend Favorite

Passage of irinotecan and its active metabolite, SN‐38, into human milk

By  

JOURNAL OF CLINICAL PHARMACY & THERAPEUTICS, Vol. 41, Iss. 5, 2016-10 ,pp. : 579-582

John Wiley & Sons Inc

Access to resources Recommend Favorite

Effect of lopinavir/ritonavir on the pharmacokinetics of selexipag an oral prostacyclin receptor agonist and its active metabolite in healthy subjects

By  

BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (ELECTRONIC), Vol. 306-5251, Iss. 4, 2015-10 ,pp. : 670-677

John Wiley & Sons Inc

Access to resources Recommend Favorite